Fri, Jul 25, 2014, 11:42 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Insmed Incorporated Message Board

  • kvnmccdd kvnmccdd Jun 7, 2014 3:02 PM Flag

    Thank you Checkyourshorts ATS International Conference 2014: NTM Goes Under the Microscope

    ATS International Conference 2014: NTM Goes Under the Microscope

    ...The Research meeting was co-sponsored by ATS and NTM Info & Research. NTM Info is pleased to have been able to support and participate in this meeting, the findings of which will be published as a paper in one of the ATS publications later this year, once the committee publishes its notes.

    In addition to the NTM Research Agenda Meeting, this year’s conference held in San Diego, CA, featured a prominent booth in the Exhibition Hall by Insmed (the makers of ARIKAYCE™, an inhaled liposomal Amikacin which just completed Phase II clinical trials), as well as numerous conference workshops and a symposium on NTM sponsored by Insmed. The attention-grabbing booth featured an informative video on NTM lung disease playing on TV screens mounted on both sides of the booth, as well as NTMir’s flagship publication, “Insight: A Patient’s Perspective,” and other informational materials. (Click here for pictures of the booth and symposium.)

    The Insmed-sponsored symposium conducted in partnership with NTMir, titled “NTM Isn’t Waiting, Neither Should You,” was a resounding success. With initial attendance expected to reach 125 people, the final count was 305 clinicians and researchers who showed up to join an interactive learning-based event. Symposium faculty Dr. Charles Daley, Dr. Kevin Winthrop, Dr. Ken Olivier and Dr. David Griffith posed questions to the audience members, who were able to answer using iPads set up at each table, with the results tabulated in real time and displayed on screens around the room. (Click here for pictures from the symposium.)

 
INSM
17.50-0.11(-0.62%)Jul 25 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.